top of page
Search

Beyond the Numbers: The Human Impact of Cardiovascular Disease and the Role of Clinical Partnerships

  • Writer: FutureMeds
    FutureMeds
  • Aug 7
  • 2 min read

With a 90% increase in cardiovascular prevalence on the horizon, the urgency for operational excellence and collaborative innovation has never been greater. ESC Congress 2025 is the moment for sponsors, CROs, and clinical partners to come together and rewrite the future of cardiovascular care.

ree

By 2050, cardiovascular disease will claim 35.6 million lives every year. This staggering figure marks a 73.4% increase in crude mortality and a 90% rise in disease prevalence compared to 2025. It reflects not just a shift in data, but a human crisis in the making—millions of families disrupted by grief, disability, and chronic illness. Behind each number is a story that could have ended differently.


The coming decades will be shaped by what we do now. With populations ageing and lifestyle-related risk factors like blood pressure, cholesterol, and diet continuing to drive disease progression, there’s no time to wait.


That’s why we’re heading to ESC Congress 2025 in Madrid—to be part of the solution.


“Cardiovascular disease is not just today’s problem; it’s tomorrow’s public health crisis unfolding before our eyes. With projections showing the global death toll rising to 35.6 million annually by 2050, the need for action is undeniable. And advances in research require committed collaboration and agile execution.”

— Cameron Glen, Vice President of Global Business Development



From early feasibility to last patient out, our dedicated site teams have supported over 65 cardiovascular trials across heart failure, hypertension, and lipid disorders, translating innovation into evidence and helping clients translate evidence into impact.


“ESC 2025 represents a unique opportunity to unite with sponsors and CROs in a shared mission: to turn groundbreaking research into accessible, life-saving treatments, and make a measurable difference in cardiovascular health globally.”

— Cameron Glen, Vice President of Global Business Development


We’re eager to meet with industry partners working on addressing today's and tomorrow's challenges.


If your team will be in Madrid, we’d love to connect, whether it’s a strategic meeting or an informal catch-up on the latest in cardiovascular research delivery.


Let’s connect at ESC Congress 2025 in Madrid. Contact us to schedule a meeting with Cameron Glen or any member of our team.

 
 
 

Comments


Commenting on this post isn't available anymore. Contact the site owner for more info.
bottom of page